Volume 56, Issue 2 pp. 178-179

Identification of a new HLA-B*39 allele: HLA-B*3924

J.T. Cook

J.T. Cook

Transplantation Immunology, Nuffield Department of Surgery, Oxford Transplant Centre, Churchill Hospital, Oxford, United Kingdom

Search for more papers by this author
S. Day

S. Day

United Kingdom Transplant Support Service Authority, Stoke Gifford, Bristol, United Kingdom

Search for more papers by this author
P.P.J. Dunn

P.P.J. Dunn

United Kingdom Transplant Support Service Authority, Stoke Gifford, Bristol, United Kingdom

Search for more papers by this author
K.I. Welsh

K.I. Welsh

Transplantation Immunology, Nuffield Department of Surgery, Oxford Transplant Centre, Churchill Hospital, Oxford, United Kingdom

Search for more papers by this author
M. Bunce

M. Bunce

Transplantation Immunology, Nuffield Department of Surgery, Oxford Transplant Centre, Churchill Hospital, Oxford, United Kingdom

Search for more papers by this author
First published: 25 December 2001
Citations: 5
Correspondence to:Julia Cook
Transplantation Immunology
Nuffield Department of Surgery
Oxford Transplant Centre
Churchill Hospital
Oxford, OX3 7LJ
UK
Fax: +44 1865 226162
e-mail: [email protected]

Abstract:

We have identified a new HLA-B*39 allele through polymerase chain reaction (PCR) using sequence-specific primers (SSP) and sequence-based typing of exons 2 and 3. This novel allele was identified in three HLA-identical siblings of Turkish origin. This allele only differs from HLA-B*3903 at a unique single nucleotide substitution (T for C) at position 365 in exon 3 which results in an amino acid change in codon 98 of methionine (ATG) to threonine (ACG). The sequencing enabled the development of a monospecific PCR-SSP reaction which can be used to discriminate between HLA-B*3924 and other B*39 alleles.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.